Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Talvik, M. Articles by Farde, L. Search for Related Content PubMed Citation Articles by Talvik, M. Articles by Farde, L. Schizophrenia Spectrum Disorders Other Neuroleptics MRI PET

No Support for Regional Selectivity in Clozapine-Treated Patients: A PET Study With [¹¹C]Raclopride and [¹¹C]FLB 457

OBJECTIVE: The authors’ goal was to test the hypothesis of extrastriatal D₂ receptor selectivity as the mechanism of action of clozapine. METHOD: Positron emission tomography (PET) was used to examine extrastriatal as well as striatal dopamine D₂ receptor occupancy in four patients treated with clozapine and three patients treated with haloperidol. The reference radioligand [¹¹C]raclopride was used for determination of D₂ receptor occupancy in the striatum. The radioligand [¹¹C]FLB 457 was chosen for determination of D₂ receptor occupancy in the thalamus, the temporal cortex, and the frontal cortex. RESULTS: In patients treated with haloperidol the D₂ receptor occupancy was high in all examined brain regions. In clozapine-treated patients the D₂ receptor occupancy was relatively low in both the striatum and the extrastriatal regions. CONCLUSIONS: The results from the present study give no support for the hypothesis of regional selectivity as the mechanism of action for clozapine.

This article has been cited by other articles:

				J. M. Stone, J. M. Davis, S. Leucht, and L. S. Pilowsky Cortical Dopamine D2/D3 Receptors Are a Common Site of Action for Antipsychotic Drugs--An Original Patient Data Meta-analysis of the SPECT and PET In Vivo Receptor Imaging Literature Schizophr Bull, July 1, 2009; 35(4): 789 - 797. [Abstract] [Full Text] [PDF]

				A. Catafau, M. Penengo, G. Nucci, S. Bullich, I. Corripio, E. Parellada, C. Garcia-Ribera, R. Gomeni, E. Merlo-Pich, and Barcelona Clinical Imaging in Psychiatry Group Pharmacokinetics and time-course of D2 receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patients J Psychopharmacol, November 1, 2008; 22(8): 882 - 894. [Abstract] [PDF]

				G. Grunder, C. Fellows, H. Janouschek, T. Veselinovic, C. Boy, A. Brocheler, K. M. Kirschbaum, S. Hellmann, K. M. Spreckelmeyer, C. Hiemke, et al. Brain and Plasma Pharmacokinetics of Aripiprazole in Patients With Schizophrenia: An [18F]Fallypride PET Study Am J Psychiatry, August 1, 2008; 165(8): 988 - 995. [Abstract] [Full Text] [PDF]

				W.-D. Heiss and K. Herholz Brain Receptor Imaging J. Nucl. Med., February 1, 2006; 47(2): 302 - 312. [Abstract] [Full Text] [PDF]

				R. M. Moresco, R. Cavallaro, C. Messa, D. Bravi, C. Gobbo, L. Galli, G. Lucignani, C. Colombo, G. Rizzo, I. Velona, et al. Cerebral D2 and 5-HT2 Receptor occupancy in Schizophrenic Patients Treated with Olanzapine Or Clozapine J Psychopharmacol, September 1, 2004; 18(3): 355 - 365. [Abstract] [PDF]

				H. M. JONES and L. S. PILOWSKY Dopamine and antipsychotic drug action revisited The British Journal of Psychiatry, October 1, 2002; 181(4): 271 - 275. [Full Text] [PDF]

				R. M. KESSLER and H. Y. MELTZER Regional Selectivity in Clozapine Treatment? Am J Psychiatry, June 1, 2002; 159(6): 1064 - 1065. [Full Text]

				L. S. PILOWSKY and P. J. ELL Clozapine and dopamine D(2) blockade. Am J Psychiatry, February 1, 2002; 159(2): 324 - 325. [Full Text] [PDF]

				D. F. Wong In Vivo Imaging of D2 Dopamine Receptors in Schizophrenia: The Ups and Downs of Neuroimaging Research Arch Gen Psychiatry, January 1, 2002; 59(1): 31 - 34. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us